Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fucose-1-phosphate guanylyltransferase (FPGT) is an enzyme that catalyzes the salvage pathway in GDP-L-fucose biosynthesis by converting GTP and L-fucose-1-phosphate into GDP-L-fucose and diphosphate[1][4][3]. L-fucose, an important sugar in glycoproteins and glycolipids, plays a key role in cell–cell recognition, signaling, and immune functions[1][5]. FPGT is especially significant in tissues such as liver and kidney, where it enables reuse of fucose derived from glycoprotein and glycolipid turnover[1][3]. This enzyme belongs to the family of transferases, specifically the nucleotidyltransferases that transfer phosphorus-containing nucleotide groups[7][4]. The FPGT gene encodes this protein, and its dysfunction can affect glycosylation through impaired fucose salvage and utilization[1][3][5]. There is no current evidence for drugs directly targeting FPGT or its use as a biomarker or having known safety concerns in therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fucose-1-phosphate guanylyltransferase (FPGT).